New York, NY -- (SBWIRE) -- 03/11/2013 -- Alpha Penny Stock knows Hot stocks, especially hot Small and Mid-Capstocks, and knows that The RIGHT Stock can offer the HIGHEST percentage gains of any stocks in the market. At AlphaPennyStock, we highlight and alert on the best penny stocks and value investments in stocks on any stock market. The stock picks issued at AlphaPennyStockare the top penny stocks that we are evaluating for the best return on investment.
UnitedHealth Group Inc.(NYSE:UNH) fell -0.02% and closed at $53.81 with the total traded volume of 4.59 million shares after its leading chronic disease experts, Deneen Vojta, M.D., and Richard Smith, M.D., addressed the 25th Anniversary Nobel Peace Prize Forum, March 8-10 at Augsburg College in Minneapolis.
The company is scheduled to participate at Barclays Healthcare Conference to be held on Mar 12, 2013 at 10:45AM EDT. Its opening price was $53.97 and its shares traded within the range of $53.52-$54.25. This company has earnings per share of $5.28 with the net profit margin of 5.00% and operating margin of 8.37%. The company now has market cap of about $55.15 billion.
Will UNH Get Buyers Even After The Recent Rally? Find Out Here
Express Scripts Holding Company (NASDAQ:ESRX) gained +0.20% with the closing price of $58.81 after SunTrust analysts repeated its buy rating on the stock. The overall volume in the last trading session was 3.73 million shares. Its fifty two week range was $49.79-$66.06. The total market capitalization remained $48.14 billion.
The stock is ahead its 52 week low with 18.12% and its last month price volatility remained 2.19%. Its beta coefficient was 1.06 with a target price of $64.00. In its share capital, the company has 818.50 million outstanding shares while 813.73 million shares have been floated in market.
Why Should Investors Buy ESRX After The Recent Gain? Just Go Here and Find Out
It has insider ownership of 0.13% with institutional ownership remained 86.95%. Earnings per share this year dropped -29.00% while the five year EPS growth rate was +9.54%.
Aetna Inc.(NYSE:AET) moved up +1.88% and closed at $50.52 in the last trading session with the overall traded volume of 3.38 million shares, lower versus the average volume of 3.40 million shares. The company disclosed in its findings that opioid use declined among 4.3 million members by 15 percent between January 2010 and January 2012. These results were disclosed at the Pharmacy Benefit Management Institute’s Drug Benefit Conference held February 18 – 20 in Las Vegas.
Its 52 weeks high price was $51.14 and suffered lowest price of $34.58 in the same period.
Will AET Continue To Move Higher? Find Out Here
AET has total debt-to-equity ratio is 0.62. It has market cap of $16.57 billion while its total outstanding shares are 328.00million. The stock beta value stands at 1.19 times.
About Alpha Penny Stock
Alphapennystock.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. We strive to live up to our name, Alpha, being the leader in the industry. It is important to understand that these stocks also carry high risk. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.
We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)